Indianapolis-based Eli Lilly and Company announced plans to invest an additional $50 million in an innovative, global partnership to fight Multi-Drug Resistant Tuberculosis (MDR-TB). The announcement is being made in conjunction with World TB Day activities.
The Lilly MDR-TB Partnership is an international alliance of 14 public and private organizations, including businesses, humanitarian organizations, academic institutions, and professional health care associations.
For more on World TB Day, 24 March, click here.
No comments:
Post a Comment